Nuvectis Pharma Inc NVCT

US Biotechnology

$20.94 ▼ -0.38% ($-0.08)

Open $20.37

Prev Close $21.02

Day Range $19.98 – $21.31

52W Range $5.55 – $29.28

Market Cap $722.85M

Beta -0.21

EPS (TTM) $-1.89

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2022-02-04
Shares Out.	32,580,000
Website	nuvectis.com/ ↗
Phone	13608377232
Employees	13
Revenue	$0
Gross Profit	$0
Net Income	-$30.1M
Free Cash Flow	-$40.3M
Total Assets	$140.8M
Total Liabilities	$14.2M
Equity	$126.6M

About Nuvectis Pharma Inc

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Nuvectis Pharma Inc is a publicly traded company under the ticker symbol NVCT on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.